KOSDAQ · Healthcare · ₩257B
₩10,250-0.87%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 4.9% · as of 26.09.11
Among 15 신약 개발 peers
Quarterly Revenue Growth
“이번 분기는 새 제품 출시보다 실제 처방 확대가 더 중요해졌어요.”
In the company's words · 2026 2분기 filing